The microRNA miR-433 promotes renal fibrosis by amplifying the TGF-β/Smad3-Azin1 pathway.
暂无分享,去创建一个
H. Lan | Weiqin Yang | Arthur C K Chung | Rong Li | A. Chung | Hui Y Lan | Rong Li | Yuan Dong | Xiang Zhong | X. Zhong | Y. Dong | Weiqin Yang | Yuan Dong | Xiang Zhong
[1] S. Friedman,et al. A polymorphism that delays fibrosis in hepatitis C promotes alternative splicing of AZIN1, reducing fibrogenesis , 2011, Hepatology.
[2] A. Roberts. Molecular and Cell Biology of TGF-β , 1998, Mineral and Electrolyte Metabolism.
[3] H. Lan,et al. Latent TGF-beta1 protects against crescentic glomerulonephritis. , 2008, Journal of the American Society of Nephrology : JASN.
[4] K. Lai,et al. Disruption of the Smad7 gene promotes renal fibrosis and inflammation in unilateral ureteral obstruction (UUO) in mice. , 2009, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[5] F. Strutz,et al. The importance of tubulointerstitial damage in progressive renal disease. , 2000, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[6] H. Lan,et al. The Protective Role of Smad7 in Diabetic Kidney Disease: Mechanism and Therapeutic Potential , 2011, Diabetes.
[7] Yong Liu,et al. MicroRNA-target pairs in human renal epithelial cells treated with transforming growth factor β1: a novel role of miR-382 , 2010, Nucleic acids research.
[8] S. H. Kim,et al. Identification of differentially expressed genes in normal and tumor human gastric tissue. , 2000, Genomics.
[9] H. Haller,et al. MicroRNAs as mediators and therapeutic targets in chronic kidney disease , 2011, Nature Reviews Nephrology.
[10] Xiao-ming Meng,et al. Diverse roles of TGF‐β receptor II in renal fibrosis and inflammation in vivo and in vitro , 2012, The Journal of pathology.
[11] B. Bass,et al. Expression of the TGF-beta receptor gene and sensitivity to growth inhibition following polyamine depletion. , 2000, American journal of physiology. Cell physiology.
[12] Xiao-ming Meng,et al. miR-192 mediates TGF-beta/Smad3-driven renal fibrosis. , 2010, Journal of the American Society of Nephrology : JASN.
[13] K. Lai,et al. Essential role for Smad3 in angiotensin II‐induced tubular epithelial–mesenchymal transition , 2010, The Journal of pathology.
[14] E. Bottinger,et al. Smad2 protects against TGF-beta/Smad3-mediated renal fibrosis. , 2010, Journal of the American Society of Nephrology : JASN.
[15] L. Truong,et al. Angiotensin II up-regulates angiotensin I-converting enzyme (ACE), but down-regulates ACE2 via the AT1-ERK/p38 MAP kinase pathway. , 2008, The American journal of pathology.
[16] A. Szalai,et al. C-reactive protein promotes diabetic kidney disease in a mouse model of type 1 diabetes , 2011, Diabetologia.
[17] T. Haverty,et al. Mechanisms of tubulointerstitial fibrosis , 2004, Current opinion in nephrology and hypertension.
[18] Tso‐Hsiao Chen,et al. Ultrasound-microbubble-mediated gene transfer of inducible Smad7 blocks transforming growth factor-beta signaling and fibrosis in rat remnant kidney. , 2005, The American journal of pathology.
[19] Bo Liu,et al. Down-regulated miR-9 and miR-433 in human gastric carcinoma , 2009, Journal of experimental & clinical cancer research : CR.
[20] Doron Betel,et al. The microRNA.org resource: targets and expression , 2007, Nucleic Acids Res..
[21] Ivan Ovcharenko,et al. rVISTA 2.0: evolutionary analysis of transcription factor binding sites , 2004, Nucleic Acids Res..
[22] B. Bass,et al. Expression of the transforming growth factor-β gene during growth inhibition following polyamine depletion. , 1998, American journal of physiology. Cell physiology.
[23] C. Lau,et al. C-Reactive Protein Promotes Cardiac Fibrosis and Inflammation in Angiotensin II-Induced Hypertensive Cardiac Disease , 2010, Hypertension.
[24] Y. Sheen,et al. IN-1130, a novel transforming growth factor-beta type I receptor kinase (ALK5) inhibitor, suppresses renal fibrosis in obstructive nephropathy. , 2006, Kidney international.
[25] Ling Yu,et al. Combining TGF-beta inhibition and angiotensin II blockade results in enhanced antifibrotic effect. , 2004, Kidney international.
[26] K. Lai,et al. Mechanism of chronic aristolochic acid nephropathy: role of Smad3. , 2010, American journal of physiology. Renal physiology.
[27] Cheuk-Man Yu,et al. TGF-β/Smad3 signaling promotes renal fibrosis by inhibiting miR-29. , 2011, Journal of the American Society of Nephrology : JASN.
[28] Xiaowei Wang. miRDB: a microRNA target prediction and functional annotation database with a wiki interface. , 2008, RNA.
[29] R. Kucherlapati,et al. Deletion of Smad2 in Mouse Liver Reveals Novel Functions in Hepatocyte Growth and Differentiation , 2006, Molecular and Cellular Biology.
[30] R. Kalluri,et al. BMP-7 counteracts TGF-β1–induced epithelial-to-mesenchymal transition and reverses chronic renal injury , 2003, Nature Medicine.
[31] C. Kahana. Regulation of cellular polyamine levels and cellular proliferation by antizyme and antizyme inhibitor. , 2009, Essays in biochemistry.
[32] L. Lim,et al. MicroRNA targeting specificity in mammals: determinants beyond seed pairing. , 2007, Molecular cell.
[33] H. Lan,et al. Chemokines in renal injury. , 2011, Journal of the American Society of Nephrology : JASN.
[34] H. Lan,et al. Smad7 suppresses renal fibrosis via altering expression of TGF-β/Smad3-regulated microRNAs. , 2013, Molecular therapy : the journal of the American Society of Gene Therapy.
[35] J. Rossi,et al. TGF-β activates Akt kinase via a microRNA-dependent amplifying circuit targeting PTEN , 2009, Nature Cell Biology.
[36] A. Hatzigeorgiou,et al. A guide through present computational approaches for the identification of mammalian microRNA targets , 2006, Nature Methods.
[37] J. Zavadil,et al. Transforming Growth Factor-β and microRNA:mRNA Regulatory Networks in Epithelial Plasticity , 2007, Cells Tissues Organs.
[38] Xiao-ming Meng,et al. miR-21 is a key therapeutic target for renal injury in a mouse model of type 2 diabetes , 2013, Diabetologia.
[39] S. Hubchak,et al. TGF-β signal transduction and mesangial cell fibrogenesis , 2003 .
[40] A. Keren-Paz,et al. Antizyme Affects Cell Proliferation and Viability Solely through Regulating Cellular Polyamines* , 2011, The Journal of Biological Chemistry.
[41] A. Roberts,et al. Targeted disruption of SMAD3 results in impaired mucosal immunity and diminished T cell responsiveness to TGF‐β , 1999, The EMBO journal.
[42] C. Kahana,et al. The Role of Polyamines in Supporting Growth of Mammalian Cells Is Mediated through Their Requirement for Translation Initiation and Elongation*♦ , 2010, The Journal of Biological Chemistry.
[43] H. Lan,et al. TGF-β/Smad signaling in kidney disease. , 2012, Seminars in nephrology.
[44] R. Quigg,et al. MicroRNA‐377 is up‐regulated and can lead to increased fibronectin production in diabetic nephropathy , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[45] R. Morishita,et al. Inhibition of renal fibrosis by gene transfer of inducible Smad7 using ultrasound-microbubble system in rat UUO model. , 2003, Journal of the American Society of Nephrology : JASN.
[46] Xiao-ming Meng,et al. Role of the TGF-β/BMP-7/Smad pathways in renal diseases. , 2013, Clinical science.
[47] Robert H. Jenkins,et al. Loss of MicroRNA-192 promotes fibrogenesis in diabetic nephropathy. , 2010, Journal of the American Society of Nephrology : JASN.
[48] Compagnone Alessandra,et al. Polyamines modulate epithelial-to-mesenchymal transition , 2012, Amino Acids.
[49] A. Kulkarni,et al. Autoimmune manifestations in the transforming growth factor-beta 1 knockout mouse. , 1996, Blood.
[50] T. Pawson,et al. Deletion of Exon I of SMAD7 in Mice Results in Altered B Cell Responses , 2006, The Journal of Immunology.
[51] K. Sharma,et al. Potential Role of TGF-β in Diabetic Nephropathy , 1998, Mineral and Electrolyte Metabolism.
[52] John J Rossi,et al. MicroRNA-192 in diabetic kidney glomeruli and its function in TGF-β-induced collagen expression via inhibition of E-box repressors , 2007, Proceedings of the National Academy of Sciences.
[53] H. Lan,et al. Transforming growth factor-β and Smads. , 2011, Contributions to nephrology.
[54] H. Lan,et al. Blockade of NFkappaB activation and renal inflammation by ultrasound-mediated gene transfer of Smad7 in rat remnant kidney. , 2005, Kidney international. Supplement.
[55] Sun-Mi Park,et al. The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2. , 2008, Genes & development.
[56] H. Lan,et al. Smad7 gene therapy ameliorates an autoimmune crescentic glomerulonephritis in mice. , 2007, Journal of the American Society of Nephrology : JASN.
[57] Xiao-ming Meng,et al. Smad3-mediated upregulation of miR-21 promotes renal fibrosis. , 2011, Journal of the American Society of Nephrology : JASN.
[58] J. Kopp,et al. Advanced glycation end-products induce tubular CTGF via TGF-beta-independent Smad3 signaling. , 2010, Journal of the American Society of Nephrology : JASN.
[59] H. Lan. Diverse Roles of TGF-β/Smads in Renal Fibrosis and Inflammation , 2011, International journal of biological sciences.
[60] Huifang M. Zhang,et al. Activation of TGF-β-Smad signaling pathway following polyamine depletion in intestinal epithelial cells , 2003 .
[61] K. Lai,et al. Mice overexpressing latent TGF-beta1 are protected against renal fibrosis in obstructive kidney disease. , 2008, American journal of physiology. Renal physiology.
[62] A. Roberts,et al. Targeted disruption of TGF-beta1/Smad3 signaling protects against renal tubulointerstitial fibrosis induced by unilateral ureteral obstruction. , 2003, The Journal of clinical investigation.
[63] Hong-Jian Zhu,et al. Smad7 inhibits fibrotic effect of TGF-Beta on renal tubular epithelial cells by blocking Smad2 activation. , 2002, Journal of the American Society of Nephrology : JASN.
[64] G. Remuzzi,et al. Pathophysiology of progressive nephropathies. , 1998, The New England journal of medicine.
[65] R. Atkins,et al. A novel method of microwave treatment for detection of cytoplasmic and nuclear antigens by flow cytometry. , 1996, Journal of immunological methods.
[66] H. Lan,et al. Angiotensin II Induces Connective Tissue Growth Factor and Collagen I Expression via Transforming Growth Factor–&bgr;–Dependent and –Independent Smad Pathways: The Role of Smad3 , 2009, Hypertension.
[67] Xiao-ming Meng,et al. Disruption of Smad4 impairs TGF-β/Smad3 and Smad7 transcriptional regulation during renal inflammation and fibrosis in vivo and in vitro. , 2012, Kidney international.
[68] K. Sharma,et al. Mechanisms of kidney fibrosis and the role of antifibrotic therapies , 2009, Current opinion in nephrology and hypertension.
[69] A. Szalai,et al. C-reactive protein promotes acute renal inflammation and fibrosis in unilateral ureteral obstructive nephropathy in mice , 2011, Laboratory Investigation.